GPhC Homepage

Sodium Valproate resources and informationRevalidation requirements from October 2022

Supplying Sodium Valproate safely: See the latest guidance on the new rules

Welcome

We regulate pharmacists, pharmacy technicians and pharmacies in Great Britain.  We work to assure and improve standards of care for people using pharmacy services.

Updates

Valproate National Patient Safety Alert

29 November 2023
 - 
The Medicines and Healthcare products Regulatory Agency (MHRA) have issued a Valproate National Patient Safety Alert in advance of new regulatory measure being introduced from January 2024.

​​GPhC Council agrees to increase fees​

14 November 2023
 - 
The General Pharmaceutical Council (GPhC) has agreed to increase fees by 7.5% from April 2024

New Chief Pharmacy Officer and Chief Enforcement Officer announced for GPhC

27 October 2023
 - 
The General Pharmaceutical Council (GPhC) has appointed two new executive-level members of staff

New rules on the way medicines containing valproate are dispensed come into force

11 October 2023
 - 
Medicines containing valproate must now be sold or supplied in the manufacturer’s original outer packaging, with warnings about the risks of taking the medication during pregnancy

Temporary register to close in March 2024

22 September 2023
 - 
The UK Government has asked the General Pharmaceutical Council and other relevant health professional regulators to close our temporary registers on 31 March 2024.